Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Vaccine|January 1, 2008
AIDS vaccine: efficacy, safety and ethicsVeljko Veljkovic, Nevena Veljkovic, Sanja Glisic, et al.Expert Opinion on Drug Discovery|June 1, 2012
The role of long-range intermolecular interactions in discovery of new drugsNevena Veljkovic, Sanja Glisic, Vladimir Perovic, et al.Current Pharmaceutical Biotechnology|March 21, 2012
Simple and general criterion for "in silico" screening of candidate HIV drugsNevena Veljkovic, Sanja Glisic, Jelena Prljic, et al.Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Simple criterion for selection of flavonoid compounds with anti-HIV activityVeljko Veljkovic, Jean-François Mouscadet, Nevena Veljkovic, et al.Expert Opinion on Drug Discovery|May 1, 2015
Preclinical discovery and development of maraviroc for the treatment of HIVNevena Veljkovic, Jelica Vucicevic, Sabrina Tassini, et al.Current Protein & Peptide Science|October 16, 2008
Discovery of new therapeutic targets by the informational spectrum methodNevena Veljkovic, Sanja Glisic, Jelena Prljic, et al.Discoveries (Craiova, Romania)|April 21, 2020
Simple Chemoinformatics Criterion Using Electron Donor-Acceptor Molecular Characteristics for Selection of Antibiotics Against Multi-Drug-Resistant BacteriaVeljko Veljkovic, Sanja Glisic, Vladimir Perovic, et al.Expert Opinion on Drug Discovery|July 1, 2015
Improving attrition rates in Ebola virus drug discoverySanja Glisic, Slobodan Paessler, Nevena Veljkovic, et al.BMC Structural Biology|September 30, 2009
Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptorVeljko Veljkovic, Henry L Niman, Sanja Glisic, et al.Medical Hypotheses|June 21, 2011
Can natural antibodies to VIP or VIP-like HIV-1 glycoprotein facilitate prevention and supportive treatment of breast cancer?Milena Veljkovic, Donald R Branch, Violeta Dopsaj, et al.Pageof 12